Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies

This paper describes the issues relating to the measurement of nanoparticle size, shape and dispersion when evaluating the toxicity of nanoparticles. Complete characterization of these materials includes much more than size, size distribution and shape; nonetheless, these attributes are usually the essential foundation. The measurement of particle size, particularly at scales of 100 nm or less, can be challenging under the best of conditions. Measurements that are routine in the laboratory setting become even more difficult when made under the physiological conditions relevant to toxicity studies, where the environment of the particles can be quite complex. Passive and active cellular responses, as well as the presence of a variety of nano-scale biological structures, often complicate the collection and interpretation of size and shape data. In this paper, we highlight several of the common issues faced when characterizing nanoparticles for toxicity testing and suggest general protocols to address these problems.

[1]  Matthew J Dalby,et al.  The fibroblast response to tubes exhibiting internal nanotopography. , 2005, Biomaterials.

[2]  Terence Allen,et al.  Powder sampling and particle size measurement , 1997 .

[3]  Keishi Gotoh.  Powder Technology Handbook (Third Edition) , 2006 .

[4]  Diana Boraschi,et al.  Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. , 2004, European cytokine network.

[5]  A. Churg,et al.  Mechanisms in the pathogenesis of asbestosis and silicosis. , 1998, American journal of respiratory and critical care medicine.

[6]  Scott C. Brown,et al.  Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  이수정.  해외산업간호정보 - 미국 산업안전보건연구원(National Institute for Occupational Safety and Health) 소개 , 2009 .

[8]  T. Webster,et al.  Osteoblast and Chrondrocyte Proliferation in the Presence of Alumina And Titania Nanoparticles , 2002 .

[9]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[10]  Mihail C. Roco,et al.  International strategy for Nanotechnology Research , 2001 .

[11]  Hiroaki Masuda,et al.  THEORETICAL STUDY OF THE SCATTER OF EXPERIMENTAL DATA DUE TO PARTICLE-SIZE-DISTRIBUTION , 1971 .

[12]  Lin-Sien H. Lum,et al.  NIST Recommended Practice Guide: Particle Size Characterization , 2001 .

[13]  Thomas Kuhlbusch,et al.  Particle and Fibre Toxicology BioMed Central Review The potential risks of nanomaterials: a review carried out for ECETOC , 2006 .

[14]  鋼一 井伊谷,et al.  Powder technology handbook , 1991 .

[15]  Alvin Lieberman,et al.  Liquid- and surface-borne particle measurement handbook , 1996 .

[16]  T. Allen.  Surface area and pore size determination , 1997 .

[17]  V. Castranova.  From Coal Mine Dust To Quartz: Mechanisms of Pulmonary Pathogenicity , 2000, Inhalation toxicology.

[18]  Mihail C. Roco,et al.  International strategy for nanotechnology research and development , 2001 .

[19]  B. Moudgil,et al.  Developing Experimental Approaches for the Evaluation of Toxicological Interactions of Nanoscale Materials , 2004 .

[20]  L. Mädler,et al.  Flame Synthesis of Nanoparticles , 2001 .

[21]  J. Heyder,et al.  Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. , 2004, Proceedings of the American Thoracic Society.

[22]  M. L. Laucks,et al.  Aerosol Technology Properties, Behavior, and Measurement of Airborne Particles , 2000 .

[23]  Karluss Thomas,et al.  Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  T. Hesterberg,et al.  In vitro toxicity of respirable-size particles of diatomaceous earth and crystalline silica compared with asbestos and titanium dioxide. , 1998, Journal of occupational and environmental medicine.

[25]  Clement Kleinstreuer,et al.  Comparison of micro- and nano-size particle depositions in a human upper airway model , 2005 .

[26]  K. Donaldson,et al.  Impairment of alveolar macrophage phagocytosis by ultrafine particles. , 2001, Toxicology and applied pharmacology.

[27]  N. Page,et al.  Selection of Descriptors for Particle Shape Characterization , 2003 .

[28]  Ajitkumar Jillavenkatesa,et al.  Nanopowder Characterization: Challenges and Future Directions , 2002 .